Carrillo-Reixach, Juan
Torrens, Laura
Simon-Coma, Marina
Royo, Laura
Domingo-Sàbat, Montserrat
Abril-Fornaguera, Jordi
Akers, Nicholas
Sala, Margarita
Ragull, Sonia
Arnal, Magdalena
Villalmanzo, Núria
Cairo, Stefano
Villanueva, Alberto
Kappler, Roland
Garrido, Marta
Guerra, Laura
Sábado, Constantino
Guillén, Gabriela
Mallo, Mar
Piñeyro, David
Vázquez-Vitali, María
Kuchuk, Olga
Mateos, María Elena
Ramírez, Gema
Santamaría, Manuel López
Mozo, Yasmina
Soriano, Aroa
Grotzer, Michael
Branchereau, Sophie
de Andoin, Nagore García
López-Ibor, Blanca
López-Almaraz, Ricardo
Salinas, José Antonio
Torres, Bárbara
Hernández, Francisco
Uriz, José Javier
Fabre, Monique
Blanco, Julià
Paris, Claudia
Bajčiová, Viera
Laureys, Geneviève
Masnou, Helena
Clos, Ariadna
Belendez, Cristina
Guettier, Catherine
Sumoy, Lauro
Planas, Ramón
Jordà, Mireia
Nonell, Lara
Czauderna, Piotr
Morland, Bruce
Sia, Daniela
Losic, Bojan
Buendia, Marie Annick
Sarrias, Maria Rosa
Llovet, Josep M.
Armengol, Carolina
Funding for this research was provided by:
Instituto de Salud Carlos III
Agència de Gestió d'Ajuts Universitaris i de Recerca
European Commission
This article is maintained by: Elsevier
Article Title: Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Journal Title: Journal of Hepatology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jhep.2020.03.025
Content Type: article
Copyright: © 2020 European Association for the Study of the Liver. Published by Elsevier B.V.